• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

tcpO2, arterial blood flow and lactate/pyruvate modifications induced by a single dose of naftidrofuryl IV during stage III lower-limb arteriopathies.

作者信息

Pointel J P, Thomas C, Mosnier M, Percebois G, Debry G

出版信息

Angiology. 1986 Sep;37(9):647-53. doi: 10.1177/000331978603700905.

DOI:10.1177/000331978603700905
PMID:3767072
Abstract

A single dose of 600 mg of naftidrofuryl perfused IV during three hours in 12 stage III arteriopathic patients did not modify the average blood flow at the calf but did significantly increase transcutaneous oxygen pressure (33 vs 52 mmHg) and also improved lactates (1.44 vs 0.88 mmol/liter), pyruvate (59 vs 79 mumol/liter), and lactates-pyruvates ratio (33.48 vs 20.92).

摘要

相似文献

1
tcpO2, arterial blood flow and lactate/pyruvate modifications induced by a single dose of naftidrofuryl IV during stage III lower-limb arteriopathies.
Angiology. 1986 Sep;37(9):647-53. doi: 10.1177/000331978603700905.
2
[Transcutaneous measures of oxygen partial pressure and capillaroscopic parameters as affected by naftidrofuryl in patients with obliterative arteriopathies, Fontaine stages II-IV].
J Mal Vasc. 1987;12(1):78-81.
3
[Naftidrofuryl in stages III and IV of peripheral arterial occlusive disease].萘呋胺酯用于外周动脉闭塞性疾病Ⅲ期和Ⅳ期的治疗
Vasa Suppl. 1988;24:38-43.
4
[Intravenous infusion of Naftidrofuryl in the treatment of arterial diseases of the limbs. Clinical and functional study].[静脉输注萘呋胺酯治疗肢体动脉疾病。临床与功能研究]
Therapie. 1974 Nov-Dec;29(6):915-23.
5
[Double-blind study of naftidrofuryl-hydrogen oxalate in peripheral arterial occlusive disease].[草酸萘呋胺酯治疗周围动脉闭塞性疾病的双盲研究]
Med Welt. 1979 Feb 16;30(7):269-72.
6
[Effect of intravenous naftidrofuryl on the microcirculation of patients in stages III and IV of arterial occlusive disease].静脉注射奈呋胺酯对动脉闭塞性疾病Ⅲ期和Ⅳ期患者微循环的影响
Vasa Suppl. 1988;24:33-7.
7
The effect of naftidrofuryl on transcutaneous oxygen tension during a treadmill test in patients with peripheral arterial occlusive disease.萘呋胺酯对周围动脉闭塞性疾病患者在跑步机试验期间经皮氧分压的影响。
Vasc Med. 1998;3(1):9-14. doi: 10.1177/1358836X9800300103.
8
Effect of buflomedil chlorhydrate on local oxygen delivery in peripheral vascular disease.盐酸丁咯地尔对周围血管疾病局部氧输送的影响。
Angiology. 1989 Jun;40(6):559-62. doi: 10.1177/000331978904000607.
9
Some haemorheological factors and transcutaneous PO2 in patients with a peripheral arterial occlusive disease after treatment with naftidrofuryl.外周动脉闭塞性疾病患者经奈呋胺酯治疗后的一些血液流变学因素及经皮氧分压
Mater Med Pol. 1994 Jan-Mar;26(1):17-20.
10
[Action of ifenprodil tartrate in obliterative arteriopathies of the lower limbs. Combined studies using proximal blood flow and distal transcutaneous oxygen pressure].[酒石酸艾芬地尔在下肢闭塞性动脉病中的作用。使用近端血流和远端经皮氧分压的联合研究]
J Mal Vasc. 1986;11(3):242-7.

引用本文的文献

1
Oral naftidrofuryl. A review of its pharmacology and therapeutic use in the management of peripheral occlusive arterial disease.口服奈呋胺酯。其药理学及治疗外周闭塞性动脉疾病的应用综述。
Drugs Aging. 1996 Apr;8(4):299-322. doi: 10.2165/00002512-199608040-00005.